Exponent Inc. (NASDAQ:EXPO) Director Michael R. Gaulke sold 4,000 shares of the stock in a transaction that occurred on Wednesday, November 9th. The shares were sold at an average price of $59.55, for a total value of $238,200.00. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of Exponent Inc. (NASDAQ:EXPO) opened at 62.15 on Monday. Exponent Inc. has a 12 month low of $44.82 and a 12 month high of $63.00. The company has a 50-day moving average price of $53.56 and a 200-day moving average price of $52.79. The company has a market capitalization of $1.59 billion, a P/E ratio of 35.92 and a beta of 0.65.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Wednesday, October 19th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.08. Exponent had a return on equity of 15.72% and a net margin of 15.06%. The company earned $77.60 million during the quarter, compared to the consensus estimate of $74.46 million. During the same period in the previous year, the company posted $0.43 earnings per share. Exponent’s revenue for the quarter was down .4% on a year-over-year basis. On average, analysts forecast that Exponent Inc. will post $1.70 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

The business also recently declared a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Friday, December 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Wednesday, November 30th. Exponent’s payout ratio is presently 41.86%.

A number of research analysts have recently commented on EXPO shares. Zacks Investment Research downgraded Exponent from a “hold” rating to a “strong sell” rating in a research report on Friday, July 22nd. Cantor Fitzgerald started coverage on Exponent in a research report on Friday, August 26th. They set a “buy” rating and a $57.00 target price for the company.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Aperio Group LLC increased its position in shares of Exponent by 15.1% in the first quarter. Aperio Group LLC now owns 7,084 shares of the company’s stock worth $361,000 after buying an additional 932 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in Exponent by 18.6% in the first quarter. TIAA CREF Investment Management LLC now owns 127,472 shares of the company’s stock worth $6,502,000 after buying an additional 20,023 shares during the period. BlackRock Inc. boosted its stake in Exponent by 18.4% in the first quarter. BlackRock Inc. now owns 6,498 shares of the company’s stock worth $332,000 after buying an additional 1,008 shares during the period. BlackRock Group LTD boosted its stake in Exponent by 6.8% in the first quarter. BlackRock Group LTD now owns 37,744 shares of the company’s stock worth $1,925,000 after buying an additional 2,419 shares during the period. Finally, BlackRock Institutional Trust Company N.A. boosted its stake in Exponent by 0.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 644,090 shares of the company’s stock worth $32,855,000 after buying an additional 3,931 shares during the period. 90.42% of the stock is owned by institutional investors.

Exponent Company Profile

Exponent, Inc, along with its subsidiaries, is a science and engineering consulting company. The Company operates through two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, technology development, thermal sciences and vehicle analysis services.

5 Day Chart for NASDAQ:EXPO

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.